Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.78B |
| 2 |
Microsoft
MSFT
|
+$2.22B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.67B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.65B |
| 5 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$1.19B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.45B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$533M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$410M |
| 4 |
Stellantis
STLA
|
+$312M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.28% |
| 2 | Healthcare | 11.27% |
| 3 | Financials | 10.52% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 7.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2926
MediaAlpha
MAX
$781M
| $304K | ﹤0.01% |
29,460
+16,992
| +136% | +$154K |
|
2927
Ero Copper
ERO
$2.85B
| $304K | ﹤0.01% |
+15,008
| New | +$284K |
|
2928
Enact Holdings
ACT
$6.68B
| $304K | ﹤0.01% |
12,080
-4,132
| -25% | -$101K |
|
2929
ProShares UltraPro Short QQQ
SQQQ
$1.89B
| $303K | ﹤0.01% |
641
| – | – |
|
|
EVLO
2930
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $303K | ﹤0.01% |
93,193
+92,649
| +17,031% | +$275K |
|
2931
United Fire Group
UFCS
$1.34B
| $303K | ﹤0.01% |
13,366
+835
| +7% | +$20.6K |
|
2932
Enliven Therapeutics
ELVN
$4.15B
| $303K | ﹤0.01% |
14,827
+7,600
| +105% | +$154K |
|
2933
James Hardie Industries
JHX
$16.1B
| $301K | ﹤0.01% |
+11,200
| New | +$270K |
|
|
NVEI
2934
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
| $300K | ﹤0.01% |
10,149
-3,649
| -26% | -$129K |
|
|
SNBR
2935
DELISTED
Sleep Number
SNBR
| $300K | ﹤0.01% |
10,982
+26
| +0.2% | +$594 |
|
|
ESTE
2936
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $299K | ﹤0.01% |
20,940
-1,220
| -6% | -$16.3K |
|
2937
Theravance Biopharma
TBPH
$874M
| $298K | ﹤0.01% |
28,823
-7,779
| -21% | -$85.9K |
|
|
SP
2938
DELISTED
SP Plus Corporation
SP
| $298K | ﹤0.01% |
7,614
-2,568
| -25% | -$92.4K |
|
2939
Nature's Sunshine
NATR
$372M
| $298K | ﹤0.01% |
21,806
-7,263
| -25% | -$82.6K |
|
|
ATRI
2940
DELISTED
Atrion Corp
ATRI
| $298K | ﹤0.01% |
526
-160
| -23% | -$93.4K |
|
|
GRFS
2941
Grifois
GRFS
$5.35B
| $297K | ﹤0.01% |
32,441
-119,896
| -79% | -$990K |
|
2942
Teekay Tankers
TNK
$2.79B
| $297K | ﹤0.01% |
7,770
-10,475
| -57% | -$408K |
|
2943
Stoneridge
SRI
$210M
| $297K | ﹤0.01% |
15,752
-3,092
| -16% | -$54.2K |
|
2944
German American Bancorp
GABC
$1.92B
| $297K | ﹤0.01% |
10,909
-3,100
| -22% | -$90.3K |
|
2945
International Money Express
IMXI
$369M
| $296K | ﹤0.01% |
12,058
-3,785
| -24% | -$92.9K |
|
2946
CEVA Inc
CEVA
$927M
| $295K | ﹤0.01% |
11,558
-26
| -0.2% | -$655 |
|
2947
AvePoint
AVPT
$2.83B
| $295K | ﹤0.01% |
51,255
-14,966
| -23% | -$78.8K |
|
2948
Lightwave Logic
LWLG
$1.05B
| $295K | ﹤0.01% |
42,343
-14,851
| -26% | -$86.3K |
|
2949
Maravai LifeSciences
MRVI
$947M
| $295K | ﹤0.01% |
23,726
-15,010
| -39% | -$203K |
|
|
PEGR
2950
DELISTED
Project Energy Reimagined Acquisition Corp. Class A Ordinary Share
PEGR
| $295K | ﹤0.01% |
28,466
| – | – |
|
Similar funds
Barclays's Q2 2023 Portfolio in Review
As of Q2 2023, Barclays held 5,371 positions worth $158B, down 28% from $218B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays withdrew a net $70.1B in Q2 2023, closing 872 positions and reducing 1,669 holdings. Its most notable exit was DCP Midstream, LP, an estimated $47.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in State Street SPDR Nuveen ICE Municipal Bond ETF worth $36.9M.
- Barclays's largest Q2 2023 buy was State Street SPDR Nuveen ICE Municipal Bond ETF: 799,988 shares worth $36.9M.
- Barclays added most to Apple in Q2 2023, an estimated $2.78B increase.
- Barclays's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.45B.
- Barclays fully exited DCP Midstream, LP in Q2 2023, selling an estimated $47.3M.
- Barclays's ten largest holdings make up 24% of its $158B portfolio in Q2 2023.
- Barclays opened 314 new positions and closed 872 in Q2 2023.
- Barclays's portfolio value fell 28% quarter-over-quarter to $158B.
Based on Barclays's 13F filing for Q2 2023, filed 3 Aug 2023.